Growth Metrics

Insulet (PODD) EBITDA Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -343.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -178.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -283.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 72.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,505.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -184.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -3,846.00
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 829.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 829.00
Dec 31, 2025 1,231.00
Sep 30, 2025 1,581.00
Jun 30, 2025 2,757.00
Mar 31, 2025 26.00
Dec 31, 2024 309.00
Sep 30, 2024 397.00
Jun 30, 2024 104.00
Mar 31, 2024 635.00
Dec 31, 2023 2,386.00
Sep 30, 2023 249.00
Jun 30, 2023 -431.00
Mar 31, 2023 395.00
Dec 31, 2022 -229.00
Sep 30, 2022 -800.00
Jun 30, 2022 -1,321.00
Mar 31, 2022 1,077.00
Dec 31, 2021 535.00
Sep 30, 2021 768.00
Jun 30, 2021 664.00
Dec 31, 2020 -238.00
Sep 30, 2020 849.00
Jun 30, 2020 1,521.00
Mar 31, 2020 901.00
Dec 31, 2019 1,264.00
Sep 30, 2019 630.00
Jun 30, 2019 577.00
Mar 31, 2019 1,405.00
Dec 31, 2018 2,490.00
Sep 30, 2018 2,527.00
Jun 30, 2018 2,670.00
Dec 31, 2017 -220.00
Sep 30, 2017 552.00
Jun 30, 2017 427.00
Mar 31, 2017 -249.00
Dec 31, 2016 -429.00
Sep 30, 2016 3,088.00
Jun 30, 2016 821.00
Mar 31, 2016 134.00
Dec 31, 2015 -453.00
Sep 30, 2015 -525.00
Jun 30, 2015 -261.00
Mar 31, 2015 772.00
Dec 31, 2014 2,388.00
Sep 30, 2014 1,807.00
Jun 30, 2014 3,897.00
Mar 31, 2014 2,301.00
Dec 31, 2013 3,532.00
Sep 30, 2013 419.00
Jun 30, 2013 3,347.00